Ginkgo Bioworks acquires Dutch DNA Biotech
| Target | Dutch DNA Biotech |
| Buyer | Ginkgo Bioworks |
| Advisory buy side | NautaDutilh | Legal Advisory Corporate M&A Latham & Watkins | Legal Advisory Corporate M&A |
| Date announced | 2021-05-17 |
| Data Room provider | Virtual Vaults |
Story:
US-based biotech company Ginkgo Bioworks has acquired Dutch DNA Biotech, a Netherlands-based company with a proprietary platform technology focused on developing fungal strains and fermentation processes for the production of proteins and organic acids. By enabling the design of organisms that produce valuable biological products, Ginkgo is helping to accelerate the development of innovative, bio-based solutions to the world's most pressing environmental problems.
Under the terms of the acquisition agreement, Ginkgo will acquire 100% of Dutch DNA through a combination of cash and equity. In addition, certain Dutch DNA stakeholders will also be profitable upon achieving one or more technical and commercial milestones. With this acquisition, Ginkgo will integrate Dutch DNA's teams, assets and operations into the broader Ginkgo cell programming platform and expand the Ginkgo business internationally for the first time.
Source MenA
Source Ginkgo Bioworks
Source NautaDutilh